Literature DB >> 20452828

Epithelial-specific blockade of MyD88-dependent pathway causes spontaneous small intestinal inflammation.

Jianfeng Gong1, Jingyue Xu, Weiming Zhu, Xiang Gao, Ning Li, Jieshou Li.   

Abstract

Accumulating evidence suggests a role for Toll-like receptor (TLR) signaling at the intestinal epithelial cells (IECs) level for intestinal protection against exogenous injury or pathogenic infection. We hypothesized that MyD88 dependent TLR signaling at intestinal epithelium is critical for mucosal immune homeostasis. In the current study, a transgenic mouse model was generated in which a dominant-negative mutant of MyD88 (dnMyD88) was driven by an intestinal epithelial-specific murine villin promoter. Aged transgenic mice spontaneously developed chronic small intestinal inflammation, as revealed by increased CD4+ and CD8+ lymphocytes, neutrophil and macrophage infiltration, increased production of cytokines as TNF-alpha, IFN-gamma, IL-1beta, and IL-17, crypt abscesses, lymphedema, and Goblet cell depletion. The chronic inflammation was not due to increased epithelial apoptosis or permeability, but to a decreased Paneth cell-derived alpha-defensins (cryptdins) and RegIII-gamma and increased commensal bacteria translocation. Thus, epithelial MyD88-dependent pathway plays an essential role in limiting mucosal microflora penetration and preventing mucosal immunoregulation disturbance in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452828     DOI: 10.1016/j.clim.2010.04.001

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  25 in total

Review 1.  Epithelial decision makers: in search of the 'epimmunome'.

Authors:  Mahima Swamy; Colin Jamora; Wendy Havran; Adrian Hayday
Journal:  Nat Immunol       Date:  2010-07-20       Impact factor: 25.606

2.  Innate Recognition of the Microbiota by TLR1 Promotes Epithelial Homeostasis and Prevents Chronic Inflammation.

Authors:  Karishma Kamdar; Andrew M F Johnson; Denise Chac; Kalisa Myers; Vrishika Kulur; Kyle Truevillian; R William DePaolo
Journal:  J Immunol       Date:  2018-05-23       Impact factor: 5.422

3.  Lysozyme promotes the release of Toll-like receptor-2 stimulants from gram-positive but not gram-negative intestinal bacteria.

Authors:  Clett Erridge
Journal:  Gut Microbes       Date:  2010 Nov-Dec

Review 4.  Innate immune signalling at the intestinal epithelium in homeostasis and disease.

Authors:  Johanna Pott; Mathias Hornef
Journal:  EMBO Rep       Date:  2012-07-17       Impact factor: 8.807

Review 5.  Innate immunity in disease.

Authors:  David E Elliott; Sana S Siddique; Joel V Weinstock
Journal:  Clin Gastroenterol Hepatol       Date:  2014-03-12       Impact factor: 11.382

Review 6.  Epithelial Toll-like receptors and their role in gut homeostasis and disease.

Authors:  Juan F Burgueño; Maria T Abreu
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-02-26       Impact factor: 46.802

Review 7.  NF-κB in the regulation of epithelial homeostasis and inflammation.

Authors:  Andy Wullaert; Marion C Bonnet; Manolis Pasparakis
Journal:  Cell Res       Date:  2010-12-14       Impact factor: 25.617

8.  Differential induction of antimicrobial REGIII by the intestinal microbiota and Bifidobacterium breve NCC2950.

Authors:  Jane M M Natividad; Christina L Hayes; Jean-Paul Motta; Jennifer Jury; Heather J Galipeau; Vivek Philip; Clara L Garcia-Rodenas; Hiroshi Kiyama; Premysl Bercik; Elena F Verdu
Journal:  Appl Environ Microbiol       Date:  2013-10-04       Impact factor: 4.792

9.  Pro-inflammatory and pro-apoptotic properties of Human Defensin 5.

Authors:  Wuyuan Lu; Erik de Leeuw
Journal:  Biochem Biophys Res Commun       Date:  2013-06-11       Impact factor: 3.575

Review 10.  Gut microbiome and anticancer immune response: really hot Sh*t!

Authors:  S Viaud; R Daillère; I G Boneca; P Lepage; P Langella; M Chamaillard; M J Pittet; F Ghiringhelli; G Trinchieri; R Goldszmid; L Zitvogel
Journal:  Cell Death Differ       Date:  2014-05-16       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.